We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 206

The COPAXONE story in the U.S. and India: to stay or not to stay is the question

  • Michael Best & Friedrich LLP
  • -
  • India, USA
  • -
  • April 23 2014

As an update to our March 5th, April 4th and April 9th postings, The Copaxone Story in the U.S. and India, The Copaxone Story in the U.S. and India:

Vodafone strikes $1.5 billion deal for full control of Indian wireless unit

  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • -
  • India, United Kingdom, USA
  • -
  • April 18 2014

With the goal of gaining full control of its Indian wireless subsidiary, Vodafone has agreed to pay US$1.48 billion for the 11 Vodafone India (VI

Sidley Austin LLP global pricing newsletter - volume three 2014

  • Sidley Austin LLP
  • -
  • Brazil, Canada, China, European Union, France, Germany, India, United Kingdom, USA
  • -
  • April 15 2014

On October 21, 2013, Brazil’s National Agency of Supplemental Health enacted Normative Resolution 388, which mandated that all private healthcare

Remain vigilant on Indian permanent establishments

  • Caplin & Drysdale, Chartered
  • -
  • India, USA
  • -
  • April 11 2014

The US and Indian competent authorities are famously at loggerheads over the principles to be applied in transfer-pricing double tax cases. Some of

The COPAXONE story in the U.S. and India: a further update

  • Michael Best & Friedrich LLP
  • -
  • India, USA
  • -
  • April 9 2014

As an update to our March 5th and April 4th postings, The Copaxone Story in the U.S. and India and The Copaxone Story in the U.S. and India: An

The COPAXONE story in the U.S. and India: an update

  • Michael Best & Friedrich LLP
  • -
  • India, USA
  • -
  • April 4 2014

As an update to our March 5th posting, The Copaxone Story in the U.S. and India, the U.S. Supreme Court (Supreme Court) this week granted Teva

Bitcoin - calls for regulation - part eight

  • Dorsey & Whitney LLP
  • -
  • Canada, European Union, Hong Kong, India, United Kingdom, USA
  • -
  • April 1 2014

"Virtual currencies", and bitcoin in particular, continued to attract a lot of attention. The sudden shutdowns of Mt. Gox (Japan), a large bitcoin

Remain vigilant on Indian permanent establishments, even after the favorable e-Funds decision

  • Caplin & Drysdale, Chartered
  • -
  • India, USA
  • -
  • March 27 2014

The U.S. and Indian competent authorities are famously at loggerheads over the principles to be applied in transfer-pricing double-tax cases. Some of

The Galderma case gaining perspective for India

  • RK Dewan & Co
  • -
  • India, USA
  • -
  • March 18 2014

Galderma, a Swiss pharmaceutical company majoring in dermatological preparations, has been doing the rounds in the global intellectual property

Interim IRS guidance confirms per capita distributions from tribal trust resources are nontaxable

  • Holland & Knight LLP
  • -
  • India, USA
  • -
  • March 18 2014

The Notice provides that the IRS and Treasury will treat eligible per capita distributions, made from funds the Secretary of the Interior holds, in a